Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $38.8900 (1.04%) ($38.8900 - $39.5850) on Thu. May. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 32 | Latest Price | $38.8900(1.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.7% a day on average for past five trading days. | Weekly Trend | HALO declines -5.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(49%) IWO(44%) IWM(43%) IWC(42%) IWN(42%) | Factors Impacting HALO price | HALO will decline at least -1.02% in a week (0% probabilities). VIXM(-22%) UUP(-11%) VXX(-7%) TBT(-4%) GLD(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $29.92(-23.07%) | Resistance Level | $41.06 | 5 Day Moving Average | $38.42(1.22%) | 10 Day Moving Average | $39.47(-1.47%) | 20 Day Moving Average | $41.06(-5.28%) | To recent high | -12.7% | To recent low | 18.7% | Market Cap | $5.315b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |